- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.
Crisil Ratings continues Anupam Rasayan India Ltd.'s long-term rating at Crisil A+/Watch Developing for Rs 1620 Cr bank facilities & Rs 160 Cr NCDs, and short-term at Crisil A1/Watch Developing. The 'Watch Developing' outlook persists due to the proposed acquisition of Bliss GVS Pharma Ltd, expected to include Rs 300...
Anupam Rasayan promoter Anand Sureshbhai Desai has pledged an additional 2,00,000 equity shares. This action is to provide further security for the company's 160 Cr Non-Convertible Debentures (NCDs), addressing a shortfall in the existing security cover. Following this transaction, Desai's total pledged shares amount to 71,75,780, representing 6.30% of the...
Anupam Rasayan reported a strong Q1 FY27: Total Income up 36% YoY to INR 668 Cr, EBITDA up 35% YoY to INR 175 Cr (26% margin). PAT grew 6% to INR 51 Cr. This reflects momentum from new products and healthy demand. The company commercialized Ethyl Trifluoroacetate (ETFA) using flow...